Journal Article Summary

The article investigates the duration of treatment with first- and second-generation antipsychotic medications among individuals with schizophrenia. This topic is significant because consistent use of antipsychotic medications is essential for managing schizophrenia effectively, yet many patients discontinue their treatment. Understanding the factors that influence medication discontinuation can help improve adherence and overall patient outcomes.

The study analyzed data from 2,138 veterans diagnosed with schizophrenia who started treatment with specific antipsychotic medications between January 2004 and September 2006. Researchers tracked how long patients continued their prescribed medications before experiencing a gap of more than 45 days. The results showed that a large majority (84%) of patients stopped taking their initial antipsychotic during the follow-up period, which lasted up to 33 months. Among the medications studied, only risperidone was found to have a significantly higher rate of discontinuation compared to olanzapine, with various factors such as younger age, non-white race, homelessness, and substance use disorder linked to earlier discontinuation.

The study has limitations, including its focus on a specific population within a VA healthcare network, which may not represent all individuals with schizophrenia. Additionally, the findings highlight the need for improved strategies to enhance medication adherence and patient satisfaction with treatment. Patients and caregivers should discuss these findings with healthcare professionals to better understand their treatment options and address any concerns about medication adherence and potential side effects.

Medication Safety Note

This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.

Article Cited

  1. Kreyenbuhl Julie, Slade Eric P., Medoff Deborah R., Brown Clayton H., Ehrenreich Benjamin, Afful Joseph, Dixon Lisa B.. Time to Discontinuation of First- and Second-Generation Antipsychotic Medications in the Treatment of Schizophrenia. Schizophrenia research 2011. DOI: 10.1016/j.schres.2011.04.028. PMID: 21576008. PMCID: PMC5935444.

Featured Pill Pals Product

Pill Pals® is THE Express Pharmacy. Our Nationwide Pharmacy Network was created with the mission of helping you make SENSE of your meds™. As a Pharmacy Benefits Management organization, Pill Pals® gives patients the best cash prices on all meds. Pill Pals® is part of The Health Pals® Company (Health Pals®, Med Pals®, Skin Pals® etc), a vertically integrated Healthcare System that provides cost effective Medical and Pharmacy services to Employers, Patients, and more. For more information, please email [email protected]